Table of Contents
1 Table of Contents 3
1.1 List of Tables 8
1.2 List of Figures 9
2
Company Snapshot 10
2.1 Key Information 10
2.2 Company Overview 10
2.3 Financial Performance 10
2.4 Industry Outlook -- Orthopedic Devices
10
3 Business Description 11
3.1 Business Overview 11
3.2 MedSurg
Equipment 11
3.2.1 Overview 11
3.2.2 Financials 11
3.2.3 Capital
Expenditure 11
3.2.4 Market View 11
3.3 Orthopaedic Implants 11
3.3.1 Overview 11
3.3.2 Financials 11
3.3.3 Capital Expenditure 12
3.3.4 Market View 12
3.4 Major Products and Services 12
3.4.1 Overview
12
4 History 14
5 Business Strategy 17
5.1 Mission Statement
17
5.2 Strategy 17
6 Value Chain Analysis 18
6.1 Manufacturing
18
6.1.1 In House Manufacturing 18
6.2 Product Development 19
6.2.1 Regulatory Approvals 19
6.2.2 Clinical Trials 19
6.2.3 Research
and Development 19
6.3 Sales and Marketing 20
6.3.1 Partnerships and
Alliances 20
7 Competitors 21
8 Share Holding Structure 22
9 Key
Employees 23
10 Key Employee Biographies 24
11 Company Statement
25
12 Locations And Subsidiaries 28
12.1 Head Office 28
12.2 Other
Locations & Subsidiaries 28
13 Recent Developments 30
13.1 Strategy
And Business Planning 30
13.1.1 Mar 26, 2007: Stryker To Expand Sales In
India 30
13.2 Financial Announcements 30
13.2.1 Jul 17, 2008: Stryker
Reports 2Q 2008 Results 30
13.2.2 Jun 20, 2008: Stryker To Declare Q2 2008
Results 32
13.2.3 Apr 17, 2008: Stryker Declares Q1 2008 Results 32
13.2.4 Jan 23, 2008: Stryker Declares Q4 2007 Results 33
13.2.5 Dec 18,
2007: Stryker To Declare Q4 2007 Operating Results 35
13.2.6 Dec 06, 2007:
Stryker Increases Annual Dividend 35
13.2.7 Oct 17, 2007: Stryker Declares
Q3 2007 Results 35
13.2.8 Jul 19, 2007: Stryker Declares Q2 2007 Results
36
13.2.9 Apr 18, 2007: Stryker Declares Q1 2007 Results 37
13.2.10
Jan 25, 2007: Stryker Declares Q4 2006 Results 38
13.2.11 Jan 25, 2007:
Stryker Declares Year-End 2006 Results 39
13.2.12 Dec 06, 2006: Stryker
Declares Dividend 41
13.2.13 Oct 17, 2006: Stryker Declares Q3 2006
Results 41
13.2.14 Jul 20, 2006: Stryker Declares Q2 2006 Results 42
13.3 Corporate Communications 43
13.3.1 Feb 15, 2007: Stryker Appoints VP,
Strategy And Investor Relations 43
13.3.2 Jul 27, 2006: Stryker Elects
Additional Director 43
13.4 Legal and Regulatory 44
13.4.1 May 02,
2008: Stryker' s Biotech Division Gets FDA Warning Letter 44
13.4.2 Oct 12,
2007: Stryker Discloses Informal Investigation Made By SEC 44
13.4.3 Sep
27, 2007: Stryker Announces Resolution Related To March 2005 Subpoena 44
13.5 Product News 45
13.5.1 Jun 29, 2008: Stryker To Launch Patriot Bed
45
13.5.2 May 02, 2008: Stryker GI Receives 510 K Clearances For Its
Protectiscope CS Colonoscope Non-Intrapull 45
13.5.3 Mar 06, 2008: Stryker
Orthopaedics Launches Triathlon PKR And Unveils The Industry' s First Complete
Knee System With X3 Advanced Bearing 45
13.5.4 Mar 06, 2008: Stryker
Orthopaedics Launches Triathlon TS Revision System 46
13.5.5 Jan 22, 2008:
Stryker Issues Statement Regarding FDA Warning Letter 46
13.5.6 Oct 03,
2006: WEST PENN SURGEONS USE SMALLER JOINTS TO MAKE A BIGGER IMPACT ON FEMALE
PATIENTS 46
13.5.7 Jul 26, 2006: Stryker Orthopaedics Announces Knee
System With Leading Wear-Resistant Technology 47
13.5.8 Jun 01, 2006:
Orthopedic manufacturers woo women and their surgeons with new devices 47
13.5.9 Mar 31, 2006: One local doctor is using technology to get a leg up on
knee problems 47
13.5.10 Mar 15, 2006: Triathlon Knee System implanted in
more than 30,000 worldwide 48
13.5.11 Mar 06, 2006: Stryker Has Acquired
Israeli Endoscopic Solutions Developer Sightline For $50 Million 48
13.5.12 Mar 01, 2006: Alveolar distraction osteogenesis before placement of
dental implants. 48
13.5.13 Jul 01, 2005: A Comparison of Resistance to
Fracture Among Four Commercially Available Forms of Hydroxyapatite Cement.
49
13.5.14 Sep 07, 2004: OP-1 Putty is safe, effective in fusion surgery
for degenerative spondylolisthesis. 49
13.5.15 Sep 07, 2004: OP-1 Putty
Is Safe, Effective in Fusion Surgery for Degenerative Spondylolisthesis.
49
13.5.16 May 01, 2004: Surgical lights, tables and workstations: OR
staples steal the show 49
13.5.17 Nov 14, 2002: Clinical Trials Open for
New Treatment of Spinal Stenosis 50
13.5.18 Nov 14, 2002: Clinical Trials
Open for New Treatment of Spinal Stenosis 50
13.5.19 Jun 01, 2000:
Internal craniofacial distraction with biodegradable devices: early
stabilization and protected bone regeneration. 50
13.5.20 Oct 26, 1999:
Creative BioMolecules Announces New Data Supporting Development of an
OP-1-based Therapy for Parkinson' s Diseas 51
13.5.21 Oct 26, 1999:
Creative Biomolecules announces new data supporting development of an
OP-1-based therapy for Parkinson' s disease 51
13.5.22 Sep 01, 1999:
Intraoral mandibular distraction: indications, technique and long-term
results. 51
13.6 Product Approvals 51
13.6.1 May 02, 2008: Stryker GI
Receives 510 K Clearances For Its Protectiscope CS Colonoscope Non-Intrapull
51
14 Stryker Corporation Pipeline Products 53
14.1 Stryker
Corporation Product Pipeline Analysis 53
14.1.1 Stryker Corporation
Pipeline Products By Equipment Type 53
14.1.2 Stryker Corporation Pipeline
Products By Development Stage 55
14.1.3 Stryker Corporation Pipeline
Products By Therapy Area 56
14.1.4 Stryker Corporation Pipeline Products
By Clinical Trials 56
14.1.5 Stryker Corporation Pipeline Products By News
Summary 56
14.2 Flexicore Lumbar Artificial Disc 56
14.2.1 Product
Description 56
14.2.2 Product Status 57
14.2.3 Clinical Trials 57
14.3 Aquarelle 58
14.3.1 Product Description 58
14.3.2 Product Status
58
14.4 Cervicore Artificial Cervical Disc 58
14.4.1 Product
Description 58
14.4.2 Product Status 59
14.4.3 Clinical Trials 59
14.5 OP 1 Putty- Transforaminal Lumbar Interbody Fusions 61
14.5.1 Product
Description 61
14.5.2 Product Status 61
14.5.3 Clinical Trials 61
14.6 Sightline Flexible Endoscopy Product 65
14.6.1 Product Description
65
14.6.2 Product Status 65
14.7 ColonoSight system 65
14.7.1
Product Description 65
14.7.2 Product Status 65
14.8
RectoSight/ProctoSight 66
14.8.1 Product Description 66
14.8.2 Product
Status 66
14.9 ThimbleCam System 66
14.9.1 Product Description 66
14.9.2 Product Status 67
14.9.3 Product Milestone 67
14.9.4 Product
Patent Details 67
14.10 Capillary Discharge Non-Thermal Plasma 68
14.10.1 Product Description 68
14.10.2 Product Status 68
15 Appendix
69
15.1 Methodology 69
15.1.1 Coverage 69
15.1.2 Secondary
Research 70
15.1.3 Primary Research 70
15.1.4 Expert Panel Validation
71
15.2 Contact Us 71
15.3 About Global Markets Direct 71
15.4
Disclaimer 71
1.1 List of Tables
Table 1: Stryker
Corporation,Key Facts, 2007 10
Table 2: Stryker Corporation, Share
Holding Structure 22
Table 3: Stryker Corporation, Key Employees,
2007 23
Table 4: Stryker Corporation, Other Locations 28
Table 5:
Stryker Corporation Pipeline Products by Equipment Type 54
Table 6:
Stryker Corporation Pipeline Products By Development Stage 55
Table 7:
Stryker Corporation Pipeline Products By Therapy Area 56
Table 8:
Stryker Corporation Pipeline Products By Clinical Trials 56
Table 9:
Stryker Corporation Pipeline Products By News Summaries 56
1.2 List
of Figures
Figure 1: Stryker Corporation, Value Chain Analysis 18
Figure 2: Stryker Corporation Pipeline Products By Equipment Type 53
Figure 3: Stryker Corporation Pipeline Products By Equipment Type 54
Figure 4: Stryker Corporation Pipeline Products By Development Stage
55
Figure 5: Global Markets Direct Methodology 69